Medtronic initiated with an Equal Weight at Barclays
Upside potential under neutral stance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential under neutral stance.
What happened, with direct paths to the underlying reporting
Barclays initiates Medtronic with an Equal Weight rating; target price $95 vs. current price $87.09.
Target: $95
Posted price: $87.09
Analyst firm: Barclays
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.